Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.670
-0.010 (-0.60%)
At close: Dec 26, 2025, 4:00 PM EST
1.669
-0.001 (-0.05%)
After-hours: Dec 26, 2025, 7:49 PM EST
Autolus Therapeutics Market Cap
Autolus Therapeutics has a market cap or net worth of $444.46 million as of December 26, 2025. Its market cap has decreased by -41.81% in one year.
Market Cap
444.46M
Enterprise Value
402.23M
1-Year Change
-41.81%
Ranking
Category
Stock Price
$1.67
Market Cap Chart
Since June 22, 2018, Autolus Therapeutics's market cap has decreased from $969.66M to $444.46M, a decrease of -54.16%. That is a compound annual growth rate of -9.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 444.46M | -28.93% |
| Dec 31, 2024 | 625.39M | -44.17% |
| Dec 29, 2023 | 1.12B | 240.67% |
| Dec 30, 2022 | 328.81M | -13.12% |
| Dec 31, 2021 | 378.45M | -19.06% |
| Dec 31, 2020 | 467.55M | -21.26% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 22, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 963.45B |
| Johnson & Johnson | 499.93B |
| AbbVie | 407.01B |
| UnitedHealth Group | 296.16B |
| AstraZeneca | 287.19B |
| Novartis AG | 267.64B |
| Merck & Co. | 263.59B |
| Novo Nordisk | 232.28B |